Clinical efficacy of CDK4/6 inhibitor plus endocrine therapy in HR-positive/HER2-0 and HER2-low-positive metastatic breast cancer: a secondary analysis of PALOMA-2 and PALOMA-3 trials

Autor: Li, Huiyue, Wu, Yun, Zou, Haotian, Koner, Salil, Plichta, Jennifer K., Tolaney, Sara M., Zhang, Jian, He, You-Wen, Wei, Qingyi, Tang, Li, Zhang, Hui, Zhang, Baoshan, Guo, Yuanyuan, Chen, Xin, Li, Kan, Lian, Liyou, Ma, Fei, Luo, Sheng
Zdroj: In eBioMedicine July 2024 105
Databáze: ScienceDirect